Skip to main content
Fig. 2 | Respiratory Research

Fig. 2

From: Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis

Fig. 2

Current use of oral prednisolone and the risk of 11 study outcomes among asthma patients, by the average daily dose prescribed within 2 years before the index date. Abbreviations: ORadj, adjusted odds ratio; CI, confidence interval. Cells contain < 5 patients, owing to ethics regulations to preserve confidentiality, odds ratios are not displayed. *Results from main analysis (the sensitivity analysis restricted to patients with integrated hospital episode statistics yielded similar results, data not shown). Odds ratios are presented on a logarithmic scale and were adjusted for alcohol consumption, smoking status, body mass index, current or past use of inhaled bronchodilators, nonsteroidal anti-inflammatory drugs, platelet aggregation inhibitors, anticoagulants, proton pump inhibitors, vitamin D/calcium, bisphosphonates, immunosuppressants, number of prescriptions of inhaled corticosteroids (as a continuous variable), and Charlson Comorbidity Index (as a continuous variable)

Back to article page